ABSTRACT
The uptake of COVID-19 vaccines remains low despite their high effectiveness. Epidemic models that represent decision-making psychology can provide insight into the potential impact of vaccine promotion interventions in the context of the COVID-19 pandemic. We coupled a network-based mathematical model of SARS-CoV-2 transmission in Georgia, USA with a social-psychological vaccination decision-making model in which vaccine side effects, post-vaccination infections, and other unidentified community-level factors could “nudge” individuals towards vaccine resistance while hospitalization spikes could nudge them towards willingness.
Combining an increased probability of hospitalization-prompted resistant-to-willing switches with a decreased probability of willing-to-resistant switches prompted by unidentified community-level factors increased vaccine uptake and decreased SARS-CoV-2 incidence by as much as 30.7% and 24.0%, respectively. The latter probability had a greater impact than the former. This illustrates the disease prevention potential of vaccine promotion interventions that address community-level factors influencing decision-making and anticipate the case curve instead of reacting to it.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by National Institutes of Health grants R01 AI138783, R01 HD097175, and R01 AI161399.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
FUNDING
This work was supported by National Institutes of Health grants R01 AI138783, R01 HD097175, and R01 AI161399.
DISCLAIMER
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies.
CONTRIBUTIONS
KWS conceived of, designed, and conducted the analysis and wrote the manuscript. SMJ provided direction to the development of the study design, supervised the analysis, and provided critical input to the manuscript. BAL and MGQ provided input on the study design and critically reviewed and edited the manuscript.
CONFLICTS OF INTEREST
None
Data Availability
The model code and software are available on GitHub at https://github.com/EpiModel/COVID-Vax-Decisions.
